Given the significant amplification of PVT1 in ovarian cancer and the apparent clinical impact of increased expression of PVT1 (Fig 1), we examined the effect of stressors, which may pertain to the metastatic trajectory of ovarian cancers and by altering PVT1 expression in different cell lines. The gene discussed is PVT1; the disease is ovarian cancer.